Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200,509 | 218,650 | 307,466 | 187,665 | 228,321 |
| Marketable Securities | 166,661 | 214,054 | 172,542 | 88,553 | 96,048 |
| Receivables | 7,410 | 13,547 | 18,236 | 13,955 | 11,787 |
| Inventories | 3,576 | 4,101 | 2,357 | 1,547 | 2,672 |
| Other current assets | 3,408 | 3,783 | 3,788 | 4,795 | 6,317 |
| TOTAL | $391,938 | $462,133 | $514,495 | $305,923 | $354,858 |
| Non-Current Assets | |||||
| PPE Net | 4,872 | 4,264 | 4,561 | 4,769 | 5,032 |
| Investments And Advances | 31,164 | 36,961 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 3,699 | 3,844 | 7,137 |
| Other Non-Current Assets | 85,332 | 75,125 | 54,430 | 51,961 | 33,355 |
| TOTAL | $121,368 | $116,350 | $62,690 | $60,574 | $45,524 |
| Total Assets | $513,306 | $578,483 | $577,185 | $366,497 | $400,382 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,455 | 12,739 | 13,760 | 11,832 | 9,748 |
| Accrued Expenses | 57,150 | 69,022 | 48,481 | 51,641 | 46,789 |
| TOTAL | $80,499 | $102,418 | $87,491 | $84,307 | $73,828 |
| Non-Current Liabilities | |||||
| Long Term Debt | 343,692 | 332,943 | 265,843 | 269,363 | 260,625 |
| Deferred Revenues | 1,188 | 1,623 | 1,061 | 1,267 | 2,212 |
| Other Non-Current Liabilities | 12,786 | 8,945 | 6,564 | 10,091 | 10,793 |
| TOTAL | $360,774 | $346,240 | $276,806 | $281,596 | $275,904 |
| Total Liabilities | $441,273 | $448,658 | $364,297 | $365,903 | $349,732 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,484 | 78,080 | 77,819 | 68,324 | 68,110 |
| Common Shares | 80 | 80 | 79 | 70 | 70 |
| Retained earnings | -1,885,138 | -1,816,367 | -1,719,691 | -1,670,064 | -1,603,860 |
| Other shareholders' equity | 828 | 35 | 72 | -39 | 2,148 |
| TOTAL | $72,033 | $129,825 | $212,888 | $594 | $50,650 |
| Total Liabilities And Equity | $513,306 | $578,483 | $577,185 | $366,497 | $400,382 |